Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 Mar;53(3):307–312. doi: 10.1038/bjc.1986.53

Are blood group isoantigens lost from malignant prostatic epithelium? Immunohistochemical support for the preservation of the H isoantigen.

P Vowden, A D Lowe, E S Lennox, N M Bleehen
PMCID: PMC2001367  PMID: 2421753

Abstract

Previous studies while demonstrating the presence of blood group isoantigens on normal prostatic epithelium have failed to identify such antigens on malignant prostatic tissue. Using a series of blood group specific monoclonal antibodies directed towards the A, B, H and Y antigens we have reinvestigated blood group isoantigen expression in both benign prostatic hypertrophy and prostatic adenocarcinoma. Results obtained from areas of benign prostatic hypertrophy are in broad agreement with those published however though we were unable to detect either A or B blood group isoantigens Type 2H and Y isoantigens were identified in 10 of the 12 tumours. These findings, while differing from previously reported results, lend support to the suggested connection between ontogenesis, oncogenesis and blood group isoantigen expression and also support the proposed link between Type 2 structures and malignant transformation.

Full text

PDF
307

Images in this article

310Figure 1
on p.310
310Figure 2
on p.310

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chapman C. M., Allhoff E. P., Proppe K. H., Prout G. R., Jr Use of monoclonal antibodies for the localization of tissue isoantigens A and B in transitional cell carcinoma of the upper urinary tract. J Histochem Cytochem. 1983 Apr;31(4):557–561. doi: 10.1177/31.4.6827085. [DOI] [PubMed] [Google Scholar]
  2. Cooper H. S., Haesler W. E., Jr Blood group substances as tumor antigens in the distal colon. Am J Clin Pathol. 1978 Jun;69(6):594–598. doi: 10.1093/ajcp/69.6.594. [DOI] [PubMed] [Google Scholar]
  3. Finan P. J., Anderson J. R., Doyle P. T., Lennox E. S., Bleehen N. M. The prediction of invasive potential in superficial transitional cell carcinoma of the bladder. Br J Urol. 1982 Dec;54(6):720–725. doi: 10.1111/j.1464-410x.1982.tb13633.x. [DOI] [PubMed] [Google Scholar]
  4. Finan P. J., Grant R. M., de Mattos C., Takei F., Berry P. J., Lennox E. S., Bleehen N. M. Immunohistochemical techniques in the early screening of monoclonal antibodies to human colonic epithelium. Br J Cancer. 1982 Jul;46(1):9–17. doi: 10.1038/bjc.1982.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Finan P. J., Wight D. G., Lennox E. S., Sacks S. H., Bleehen N. M. Human blood group isoantigen expression on normal and malignant gastric epithelium studied with anti-A and anti-B monoclonal antibodies. J Natl Cancer Inst. 1983 Apr;70(4):679–685. [PubMed] [Google Scholar]
  6. Gupta R. K., Schuster R., Christian W. D. Loss of isoantigens A, B and H in prostate. Am J Pathol. 1973 Mar;70(3):439–447. [PMC free article] [PubMed] [Google Scholar]
  7. Hansson G. C., Karlsson K. A., Larson G., McKibbin J. M., Blaszczyk M., Herlyn M., Steplewski Z., Koprowski H. Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. Characterization by antibody binding to glycosphingolipids in a chromatogram binding assay. J Biol Chem. 1983 Apr 10;258(7):4091–4097. [PubMed] [Google Scholar]
  8. Kim Y. S., Isaacs R. Glycoprotein metabolism in inflammatory and neoplastic diseases of the human colon. Cancer Res. 1975 Aug;35(8):2092–2097. [PubMed] [Google Scholar]
  9. Lloyd K. O., Larson G., Strömberg N., Thurin J., Karlsson K. A. Mouse monoclonal antibody F-3 recognizes the difucosyl type-2 blood group structure. Immunogenetics. 1983;17(5):537–541. doi: 10.1007/BF00696877. [DOI] [PubMed] [Google Scholar]
  10. Lowe A. D., Lennox E. S., Voak D. A new monoclonal anti-A. Culture supernatants with the performance of hyperimmune human reagents. Vox Sang. 1984;46(1):29–35. doi: 10.1111/j.1423-0410.1984.tb00044.x. [DOI] [PubMed] [Google Scholar]
  11. Pann C., Kuhns W. J. Differentiation of HeLa cells with respect to blood group H antigen. Nat New Biol. 1972 Nov 1;240(96):22–24. doi: 10.1038/newbio240022a0. [DOI] [PubMed] [Google Scholar]
  12. SZULMAN A. E. THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE. III. THE A, B, AND H ANTIGENS IN EMBRYOS AND FETUSES FROM 18 MM IN LENGTH. J Exp Med. 1964 Apr 1;119:503–516. doi: 10.1084/jem.119.4.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SZULMAN A. E. The histological distribution of blood group substances A and B in man. J Exp Med. 1960 Jun 1;111:785–800. doi: 10.1084/jem.111.6.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Stellner K., Hakomori S., Warner G. S. Enzymic conversion of "H1-glycolipid" to A or B-glycolipid and deficiency of these enzyme activities in adenocarcinoma. Biochem Biophys Res Commun. 1973 Nov 16;55(2):439–445. doi: 10.1016/0006-291x(73)91106-6. [DOI] [PubMed] [Google Scholar]
  15. Thorpe S. J., Abel P., Slavin G., Feizi T. Blood group antigens in the normal and neoplastic bladder epithelium. J Clin Pathol. 1983 Aug;36(8):873–882. doi: 10.1136/jcp.36.8.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Voak D., Lennox E., Sacks S., Milstein C., Darnborough J. Monoclonal anti-A and anti-B: development as cost-effective reagents. Med Lab Sci. 1982 Apr;39(2):109–122. [PubMed] [Google Scholar]
  17. Wherrett J. R., Hakomori S. I. Characterization of a blood group B glycolipid, accumulating in the pancreas of a patient with Fabry's disease. J Biol Chem. 1973 May 10;248(9):3046–3051. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES